Efficacy and safety of amrubicin-based regimen used as first-line for extensive-disease small-cell lung cancer: A meta-analysis of randomized controlled trials.
Asia Pac J Clin Oncol
; 14(2): e81-e87, 2018 Apr.
Article
in En
| MEDLINE
| ID: mdl-29071806
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
Database:
MEDLINE
Main subject:
Anthracyclines
/
Small Cell Lung Carcinoma
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Asia Pac J Clin Oncol
Year:
2018
Document type:
Article